Where our team of guest writers discuss what they think about the current NGP US Issues.
By Acurian. Despite the existence of patient recruitment companies for twenty years or more in the United States, there is a paucity of good data supporting this tactic. However, pharmaceutical companies continue to support both central and local recruitment efforts in an attempt to reduce delays or even speed up critical trials.
At the end of last week, the chief executive of AstraZeneca unveiled a 27 percent jump in pre-tax profits for the third quarter. But, with drug patents facing expiration - currently one of the pharmaceutical industry's biggest challenges - just around the corner, it's far from an easy ride for the company.
Trevor Heritage of Symyx Technologies, Inc. discusses the value of hosted informatics in life sciences R&D.
GlaxoSmithKline’s Bill Louv tells Natalie Brandweiner of technology’s role in ensuring successful business solutions, and the responsibility of ensuring the company’s success.
NG Pharma speaks with HP’s David Medina to find out how IT can help the life science and pharma industry face some of today’s biggest challenges.